Associate Professor, Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Iran.

Dr. Aghil Sharifzadeh is an Associate Professor in the Department of Microbiology and Immunology at the Faculty of Veterinary Medicine, University of Tehran. His research primarily focuses on medical mycology, with a particular interest in dermatophytes and Candida species. Dr. Sharifzadeh has contributed significantly to understanding the antifungal susceptibility patterns and virulence factors of various fungal pathogens. His work includes studies on the antifungal susceptibility and enzymatic activities of dermatophyte species isolated from clinical specimens in Iran, as well as evaluations of virulence factors and antifungal susceptibility patterns of different Candida species isolated from the female camel genital tract. Through his research, Dr. Sharifzadeh aims to enhance the diagnosis and treatment of fungal infections in both humans and animals. His dedication to the field is evident in his numerous publications and ongoing research projects, which continue to contribute to the advancement of medical mycology.

Professional Profile

Education

Dr. Aghil Sharifzadeh has pursued advanced studies in veterinary medicine and microbiology, culminating in his current role as an Associate Professor at the University of Tehran. His academic journey has equipped him with a robust foundation in medical mycology, enabling him to conduct in-depth research on fungal pathogens affecting both humans and animals. Through his education, Dr. Sharifzadeh has developed expertise in various microbiological techniques and methodologies, which he applies in his research to investigate the characteristics and behaviors of different fungal species. His educational background has been instrumental in shaping his research interests and guiding his contributions to the field of medical mycology.

Professional Experience

Dr. Aghil Sharifzadeh serves as an Associate Professor in the Department of Microbiology and Immunology at the Faculty of Veterinary Medicine, University of Tehran. In this role, he engages in teaching, research, and mentorship, contributing to the academic development of students and the advancement of scientific knowledge in medical mycology. His professional experience includes conducting research on the antifungal susceptibility and virulence factors of various fungal pathogens, with a focus on dermatophytes and Candida species. Dr. Sharifzadeh’s work extends to studying fungal infections in animals, such as green iguanas, highlighting his commitment to understanding and addressing fungal diseases across different species. His expertise and contributions have established him as a respected figure in the field of medical mycology.

Research Interests

Dr. Aghil Sharifzadeh’s research interests lie in the field of medical mycology, with a particular focus on the antifungal susceptibility and virulence factors of dermatophytes and Candida species. He investigates the enzymatic activities of these fungal pathogens, such as keratinase, elastase, lipase, and DNase, to understand their roles in infection and pathogenicity. Dr. Sharifzadeh also explores the presence and impact of fungal agents in various animal species, including studies on mixed infections in green iguanas. His research aims to enhance the diagnosis, treatment, and prevention of fungal infections in both human and veterinary medicine. Through his work, Dr. Sharifzadeh contributes to the broader understanding of fungal diseases and their management.

Research Skills

Dr. Aghil Sharifzadeh possesses a comprehensive set of research skills in medical mycology. He is proficient in conducting antifungal susceptibility testing and analyzing the enzymatic activities of fungal pathogens. His expertise includes isolating and identifying various fungal species from clinical specimens, as well as evaluating their virulence factors. Dr. Sharifzadeh is skilled in designing and implementing research studies that investigate the characteristics and behaviors of dermatophytes and Candida species. His methodological approach combines laboratory techniques with clinical insights, enabling him to produce research that is both scientifically rigorous and clinically relevant. These skills have been instrumental in advancing knowledge in the field of medical mycology.

Awards and Honors

Dr. Aghil Sharifzadeh’s contributions to medical mycology have been recognized through various awards and honors. His research has garnered citations and acknowledgment within the scientific community, reflecting the impact and significance of his work. Dr. Sharifzadeh’s dedication to advancing the understanding of fungal pathogens and improving treatment strategies has earned him a respected position among his peers. His achievements underscore his commitment to excellence in research and his role in shaping the field of medical mycology.

Conclusion

Dr. Aghil Sharifzadeh stands as a prominent figure in the field of medical mycology, with a career dedicated to exploring the complexities of fungal pathogens and their impact on health. His extensive research on the antifungal susceptibility and virulence factors of dermatophytes and Candida species has contributed significantly to the scientific community’s understanding of these organisms. Through his role as an Associate Professor at the University of Tehran, Dr. Sharifzadeh continues to educate and mentor the next generation of scientists, fostering a culture of inquiry and innovation. His work not only advances scientific knowledge but also has practical implications for the diagnosis and treatment of fungal infections in both humans and animals. Dr. Sharifzadeh’s ongoing commitment to research excellence ensures his continued influence in the field of medical mycology.

Publications Top Notes

Title: Raisin Production by Convective–Microwave Dryer and Optimization of Ochratoxin A Content, Physicochemical, Sensory Characteristics, and Fungal Load of Raisin
Authors: Majid Behfar, Ali Heshmati, Aghil Sharifzadeh, Maryam Taghdir, Sepideh Abbaszadeh
Journal: Food Science and Nutrition
Year: 2025
Title: Impact of oleuropein on Candida albicans and Staphylococcus aureus adhesion and its mediated toxicity in Zebrafish (Danio rerio) embryos
Authors: Samira Karzani, Aghil Sharifzadeh, Bahar Nayeri-Fasaei, Aram Sharifi, Ali Pourshaban Shahrestani
Journal: Iranian Journal of Microbiology
Year: 2025
Title: Evaluation of antifungal and apoptotic effects of linalool, citral, and carvacrol separately and in combination with nystatin against clinical isolates of Pichia kudriavzevii
Authors: Aghil Sharifzadeh, Bahar Nayeri-Fasaei, Sepideh Asadi, Mahdi Houshmandzad, Mohammad Hosein Ghaffari
Journal: BMC Microbiology
Year: 2024
Citations: 2
Title: Antimicrobial and anti-biofilm properties of oleuropein against Escherichia coli and fluconazole-resistant isolates of Candida albicans and Candida glabrata
Authors: Mohammad Ali Esfandiary, Ali Reza Khosravi, Sepideh Asadi, Jalal Hassan, Aghil Sharifzadeh
Journal: BMC Microbiology
Year: 2024
Citations: 2
Title: A Report of Aflatoxicosis in Hand-fed Ewe Lambs Exhibiting Icterus After Hepatic Failure and Hemoglobinuria
Authors: Hossein Aminianfar, Nazanin Samiee, Aghil Sharifzadeh, Seyedeh Fatemeh Safavi, Moahammadreza Mokhtari Hooyeh
Journal: Iranian Journal of Veterinary Medicine
Year: 2024

Jean-Michel Bolla | Immunology and Microbiology | Best Researcher Award

Posted on 15/03/202515/03/2025 by Shen Awards

Dr. Jean-Michel Bolla | Immunology and Microbiology | Best Researcher Award

Dr. Jean Michel Bolla is a distinguished researcher specializing in microbiology, biochemistry, and antibiotic resistance. With over 30 years of experience, he has made significant contributions to understanding bacterial resistance mechanisms, particularly efflux-mediated resistance in Gram-negative bacteria. As the Director of Research at Inserm U-1261, he has led pioneering studies in bacterial physiology and virulence, as well as the development of screening platforms for antibiotic-resistant bacteria. His leadership in the Bac-Screen platform, which enables high-throughput screening of antimicrobial compounds, highlights his commitment to innovative research. Dr. Bolla has supervised multiple PhD students and postdoctoral researchers, securing major research funding from national and international agencies. His work has been recognized through invited talks at international conferences and a patent related to diagnostic tools for antibiotic resistance. Additionally, he has contributed significantly to academia through teaching roles at Aix-Marseille Université and Université de Corse. His research continues to shape the field of antimicrobial resistance, addressing one of the most pressing global health challenges. Through his expertise, leadership, and dedication to scientific advancement, Dr. Bolla has established himself as a leading figure in microbiology and antibiotic resistance research.

Professional Profile

Education

Dr. Jean Michel Bolla holds a PhD in Biochemistry and Molecular Biology from UPR9027 CNRS, Marseille, awarded in 1990. His doctoral research focused on protein export and assembly in Escherichia coli, conducted under the supervision of Dr. JM Pagès. Following his PhD, he pursued a postdoctoral fellowship at Inserm-APHP, Paris, where he worked on iron starvation responses in Listeria monocytogenes under Dr. P. Berche. His advanced training includes specialization in Campylobacter porins at the Laboratory Centre for Disease Control in Ottawa and Winnipeg, Canada in 1997 and 1998. In 2001, he obtained his Habilitation à Diriger des Recherches (HDR) from the Faculty of Medicine, Timone, Marseille, enabling him to supervise doctoral research. His extensive academic training has provided him with a strong foundation in molecular microbiology, biochemistry, and antibiotic resistance. Through continuous education and research, Dr. Bolla has developed a deep understanding of bacterial physiology, antimicrobial resistance mechanisms, and drug discovery. His educational background has been instrumental in shaping his career as a leading researcher in microbiology and antibiotic resistance, allowing him to contribute groundbreaking insights to the field.

Professional Experience

Dr. Jean Michel Bolla has had an illustrious career in research, spanning over three decades. He began as a postdoctoral researcher at Inserm-APHP, Paris, before joining Inserm as a Chargé de Recherche in 1992. Over the years, he advanced within Inserm, holding key research positions, and became Director of Research at U-1261 in 2018. He has led major research initiatives, including the establishment of the Bac-Screen platform, a high-throughput screening system for antibiotic resistance studies. From 2007 to 2011, he also served as an Associate Professor at the Université de Corse, where he contributed significantly to teaching and student mentorship. Throughout his career, Dr. Bolla has supervised seven PhD students and three postdoctoral researchers, demonstrating his commitment to training future scientists. He has been an invited speaker at multiple international conferences, sharing his expertise in antibiotic resistance. His ability to secure major research funding, including grants from CNRS, ANR, and FEAMPA, underscores his impact in the field. His leadership roles at Inserm and collaborations with various research institutions have solidified his reputation as an expert in microbiology and antibiotic resistance.

Research Interest

Dr. Jean Michel Bolla’s research primarily focuses on antibiotic resistance mechanisms, with a particular emphasis on efflux-mediated resistance in Gram-negative bacteria. His work explores the physiology and virulence of bacterial pathogens, including Campylobacter jejuni and Listeria monocytogenes. He is deeply involved in drug discovery and screening technologies, having developed the Bac-Screen platform to identify novel antimicrobial compounds and assess their mechanisms of action. His research also extends to bacterial membrane permeability, studying how bacterial outer membrane porins influence antibiotic uptake and resistance. More recently, he has been engaged in synthetic antibacterial polymer development for therapeutic applications. His work contributes to understanding multidrug resistance mechanisms, a major global health challenge, and seeks innovative solutions to combat bacterial infections. Additionally, he collaborates on projects involving diagnostic tools for detecting antimicrobial resistance, aiming to improve early detection and treatment strategies. Through his research, Dr. Bolla strives to bridge the gap between basic microbiology and clinical applications, working towards the development of effective antimicrobial strategies to tackle the increasing threat of drug-resistant bacteria worldwide.

Research Skills

Dr. Jean Michel Bolla possesses a diverse range of research skills, with expertise in molecular microbiology, biochemistry, and antimicrobial resistance. He has extensive experience in protein purification, bacterial physiology studies, and genetic manipulation of bacterial pathogens. His work in high-throughput screening techniques has been pivotal in identifying new inhibitors for efflux pumps in Gram-negative bacteria. He is proficient in drug discovery methodologies, including antibiotic susceptibility testing, mode-of-action studies, and bacterial membrane permeability analysis. Additionally, he has expertise in structural and functional analysis of bacterial outer membrane proteins, which play a crucial role in drug resistance. Dr. Bolla is also skilled in cell culture techniques, bioinformatics, and statistical analysis for interpreting large-scale screening data. His ability to secure major research funding highlights his competence in grant writing and project management. Furthermore, his teaching and mentorship experience demonstrate his ability to train and guide students in advanced microbiology research techniques. His research skills make him a valuable asset in the fight against antimicrobial resistance, as he continues to develop innovative solutions to combat bacterial infections.

Awards and Honors

Dr. Jean Michel Bolla has been recognized for his outstanding contributions to microbiology and antibiotic resistance research. In 2007, he was awarded the Inserm-Université Interface Contract, acknowledging his excellence in research and academic collaboration. His work in antimicrobial resistance has also been recognized through significant research grants from CNRS, ANR, and FEAMPA, underscoring the impact of his studies in drug discovery and bacterial resistance mechanisms. In 2019, his Bac-Screen platform was designated an Aix-Marseille University Technological Platform, a prestigious recognition that was renewed in 2023 for its critical role in antibiotic resistance research. His contributions to the field have also led to an international patent (WO 2023/139263 A1) for a diagnostic tool to detect drug resistance. Additionally, he has been an invited speaker at leading scientific conferences, including GRS-GRC Multidrug Efflux Systems and The 3rd International Electronic Conference on Antibiotics. His expertise and dedication to advancing microbial research have positioned him as a leading scientist in his field, earning him widespread recognition and respect.

Conclusion

Dr. Jean Michel Bolla is a highly accomplished microbiologist with a strong research background in antibiotic resistance and bacterial physiology. His contributions to understanding efflux-mediated resistance in Gram-negative bacteria have had a profound impact on the field. As Director of Research at Inserm U-1261, he has demonstrated exceptional leadership, securing major research funding and spearheading innovative screening platforms for antimicrobial resistance studies. His dedication to mentoring PhD students and postdoctoral researchers underscores his commitment to advancing scientific knowledge. Through his numerous research projects, international collaborations, and conference presentations, he continues to make significant strides in addressing the global challenge of antibiotic resistance. His patent for a diagnostic tool in antimicrobial resistance showcases his ability to translate research into real-world applications. Recognized through awards and honors, Dr. Bolla is a leading expert in microbiology and antimicrobial resistance. His work has positioned him as a key figure in drug discovery and bacterial resistance research, making him a strong contender for the Best Researcher Award. His career is a testament to scientific excellence, innovation, and dedication to global health challenges.

Publications Top Notes

Title: RND Efflux Pump Induction: A Crucial Network Unveiling Adaptive Antibiotic Resistance Mechanisms of Gram-Negative Bacteria
Authors: M. Novelli, Marine; J.M. Bolla, Jean Michel
Year: 2024
Citations: 5
Title: Design and Synthesis of Novel Amino and Acetamidoaurones with Antimicrobial Activities
Authors: A. Di Maio, Attilio; H. Olleik, Hamza; É. Courvoisier-Dezord, Élise; M. Maresca, Marc; M. Robin, Maxime
Year: 2024
Citations: 1
Title: Antitubercular potential and pH-driven mode of action of salicylic acid derivatives
Authors: J. Laudouze, Janïs; T. Francis, Thomas; E. Forest, Emma; P. Santucci, Pierre; J.F. Cavalier, Jean-François
Year: 2024
Title: Synthesis and antimicrobial testing of 5-fluorouracil derivatives
Authors: M.U. Patil, Mrunal Unmesh; S. Krykun, Serhii; F. Garzino, Frédéric; J.M. Bolla, Jean Michel; M. Camplo, Michel
Year: 2023
Citations: 5
Title: The membrane-active polyaminoisoprenyl compound NV716 re-sensitizes Pseudomonas aeruginosa to antibiotics and reduces bacterial virulence
Authors: G. Wang, Gang; J.M. Brunel, Jean Michel; M. Preusse, Matthias; J.M. Bolla, Jean Michel; F. van Bambeke, Francoise
Year: 2022
Citations: 11
Title: An Original and Efficient Antibiotic Adjuvant Strategy to Enhance the Activity of Macrolide Antibiotics against Gram-Negative Resistant Strains
Authors: A. Troudi, Azza; J.M. Bolla, Jean Michel; N. Klibi, Naouel; J.M. Brunel, Jean Michel
Year: 2022
Citations: 4
Title: The polyamino-isoprenyl potentiator NV716 revives disused antibiotics against Gram-negative bacteria in broth, infected monocytes, or biofilms, by disturbing the barrier effect of their outer membrane
Authors: G. Wang, Gang; J.M. Brunel, Jean Michel; H. Rodríguez-Villalobos, Héctor; J.M. Bolla, Jean Michel; F. van Bambeke, Francoise
Year: 2022
Citations: 6
Title: Nanoarchitectonics of Electrically Activable Phosphonium Self-Assembled Monolayers to Efficiently Kill and Tackle Bacterial Infections on Demand
Authors: S. Carrara, Serena; F. Rouvier, Florent; S. Auditto, Sanjana; J.M. Bolla, Jean Michel; J.M. Raimundo, Jean Manuel
Year: 2022
Citations: 6

Vladka Čurin Šerbec | Immunology and Microbiology | Women Researcher Award

Posted on 03/12/202403/12/2024 by Shen Awards

Prof. Dr. Vladka Čurin Šerbec | Immunology and Microbiology | Women Researcher Award

Head of Research Group at Blood Transfusion Centre of Slovenia, Slovenia

Vladka Čurin Šerbec is an accomplished researcher and academic with a robust background in biochemistry, molecular biology, and immunology. With extensive experience in both academic and industrial settings, she has made significant contributions to the development of monoclonal antibodies, diagnostics, and therapeutics. Through her leadership roles, including serving as the President of the Immunology Society of Slovenia, she has influenced research in the fields of immunology and biomedicine. Her research also involves collaborations with pharmaceutical industries, leading to the development of new technologies and successful commercialization of research outcomes. Known for her mentorship of numerous students and professionals, Čurin Šerbec is a respected figure in the scientific community, contributing to the education and growth of future researchers.

Professional Profile

Education

Vladka Čurin Šerbec’s academic journey began with a BChem degree from the University of Ljubljana in 1985. She continued her studies at the same institution, obtaining a Master’s degree in Biochemistry in 1988, followed by a PhD in 1991. Throughout her education, she focused on the molecular and biochemical aspects of biology, laying the foundation for her future research in immunology and biomedicine. This strong academic background has propelled her into various prestigious positions within both academia and industry, making her a leading figure in her field.

Professional Experience

Vladka Čurin Šerbec has a distinguished career that spans several decades, beginning with her research at the Jožef Stefan Institute and the Ruđer Bošković Institute in the 1980s and 1990s. Since 1993, she has held various key positions at the Blood Transfusion Centre of Slovenia (BTCS), including Head of the Department for the Production of Diagnostic Reagents and Research, Scientific Counsellor, and Vice-President of the Supervisory Board. Additionally, she served as an Associate Professor and later a Professor at the University of Ljubljana’s Medical Faculty. Her leadership in industrial and academic collaborations has been instrumental in advancing research in immunology and biomedicine.

Research Interests

Vladka Čurin Šerbec’s research interests are centered around biochemistry, molecular biology, immunology, and the development of monoclonal antibodies for diagnostic and therapeutic purposes. Her work focuses on the production of diagnostic reagents and antibodies under GMP conditions, exploring new approaches to immunological diagnostics and treatments. Additionally, she has been involved in collaborative research with the pharmaceutical industry, contributing to the development of technologies with real-world applications. Her interest in the standardization and quality assessment of immunological diagnostics has also been pivotal to her contributions to the field.

Research Skills

Vladka Čurin Šerbec possesses a broad skill set in molecular biology, biochemistry, and immunology. Her expertise includes the development and production of monoclonal antibodies, diagnostic reagents, and research tools. She is skilled in various laboratory techniques and methodologies, including immunoassays, molecular cloning, and protein expression. Additionally, Čurin Šerbec has significant experience in project leadership, having led multiple industrial, national, and international research initiatives. Her work also involves the development of biotechnological applications, such as antibody-based diagnostics and therapeutics, in close collaboration with pharmaceutical companies.

Awards and Honors

Vladka Čurin Šerbec has received numerous awards throughout her career in recognition of her scientific achievements. Notably, she was awarded the Zois Award in 2002 for her technological innovations and contributions to the field of biochemistry. She also received the Krka Award for students in organic chemistry in 1983, highlighting her early promise as a researcher. Čurin Šerbec’s achievements have been widely acknowledged by the scientific community, and her work continues to inspire future generations of researchers. She has also been honored with leadership positions in international societies, further solidifying her reputation in the field of immunology.

Conclusion

This individual demonstrates outstanding research capabilities and leadership in the fields of biochemistry, molecular biology, and immunology. Their substantial achievements in the development of monoclonal antibodies and collaborations with industry reflect both scientific excellence and practical contributions. Their commitment to research mentoring and international collaboration further strengthens their position for recognition in research excellence. With continued focus on expanding their publication record and global research influence, they have the potential for even greater impact in the scientific community.

Publication Top Notes

Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseases
- Authors: Song, F., Kovac, V., Mohammadi, B., Curin Serbec, V., Altmeppen, H.C.
- Year: 2024
- Journal: Acta Neuropathologica
- Volume: 148(1), Pages 2
Optimizing the method for expressing human monoclonal antibodies from a single peripheral blood cell from vaccinated donors
- Authors: Omejec, S., Tompa, M., Kovač, V., Šerbec, V.Č.
- Year: 2024
- Journal: Journal of Immunological Methods
- Volume: 534, Article 113747
Prion Protein: The Molecule of Many Forms and Faces
- Authors: Kovač, V., Šerbec, V.Č.
- Year: 2022
- Journal: International Journal of Molecular Sciences
- Volume: 23(3), Article 1232
- Citations: 21
Routine KIT p.D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels alone
- Authors: Šelb, J., Rijavec, M., Eržen, R., Lyons, J.J., Korošec, P.
- Year: 2021
- Journal: Journal of Allergy and Clinical Immunology
- Volume: 148(2), Pages 621–626.e7
- Citations: 36
Prion Proteins Without the Glycophosphatidylinositol Anchor: Potential Biomarkers in Neurodegenerative Diseases
- Authors: Kovač, V., Čurin Šerbec, V.
- Year: 2018
- Journal: Biomarker Insights
- Volume: 13
- Citations: 6
Targeting malignant brain tumors with antibodies
- Authors: Razpotnik, R., Novak, N., Curin Šerbec, V., Rajcevic, U.
- Year: 2017
- Journal: Frontiers in Immunology
- Volume: 8(SEP), Article 1181
- Citations: 57
Truncated prion protein PrP226 – A structural view on its role in amyloid disease*
- Authors: Kovač, V., Zupančič, B., Ilc, G., Plavec, J., Čurin Šerbec, V.
- Year: 2017
- Journal: Biochemical and Biophysical Research Communications
- Volume: 484(1), Pages 45–50
- Citations: 10
New monoclonal antibodies against bilitranslocase as a diagnostic tool in determining the progress of clear cell renal cell carcinoma
- Authors: Košir, A.B., Lukan, T., Kukovec, M., Šerbec, V.Č., Rajčević, U.
- Year: 2017
- Journal: Zdravniski Vestnik
- Volume: 86(5-6), Pages 177–184
Anchorless forms of prion protein – Impact of truncation on structure destabilization and prion protein conversion
- Authors: Kovač, V., Hafner-Bratkovič, I., Čurin Šerbec, V.
- Year: 2016
- Journal: Biochemical and Biophysical Research Communications
- Volume: 481(1-2), Pages 1–6
- Citations: 10
Flavonoid interaction with a chitinase from grape berry skin: Protein identification and modulation of the enzymatic activity
- Authors: Filippi, A., Petrussa, E., Rajcevic, U., Vianello, A., Braidot, E.
- Year: 2016
- Journal: Molecules
- Volume: 21(10), Article 1300
- Citations: 9

Hilal Ünsal | Immunology and Microbiology | Best Researcher Award

Posted on 26/11/202426/11/2024 by Shen Awards

Dr. Hilal Ünsal | Immunology and Microbiology | Best Researcher Award

Hacettepe University Faculty of Medicine, Department of Pediatric Immunology and Allergy at Hacettepe University Faculty of Medicine, Turkey

Dr. Hilal Ünsal is a distinguished pediatric allergist and clinical immunologist specializing in the diagnosis and management of allergies and immunodeficiencies in children. With extensive training and clinical experience, Dr. Ünsal has become a prominent figure in the field of pediatric allergy, contributing significantly to both clinical practice and research. Currently pursuing advanced studies in Pediatric Allergy and Clinical Immunology at Hacettepe University, she combines her clinical expertise with a strong research background, particularly in primary immunodeficiencies, food allergies, and asthma. Her work has been published in several reputable journals, and she is an active participant in international conferences, reflecting her commitment to advancing medical knowledge and improving patient outcomes.

Professional Profile

Scopus Profile

Education

Dr. Ünsal earned her Medical Degree from Gazi University, Faculty of Medicine in 2012, where she graduated as an honor student. She then pursued a residency in pediatrics at Health Sciences University Dr. Sami Ulus Maternity, Child Health and Diseases Training and Research Hospital, completing her training in 2018. Currently, she is completing a Clinical Fellowship in Pediatric Allergy and Clinical Immunology at Hacettepe University, a program that is enhancing her expertise in the immunologic aspects of pediatric diseases. Dr. Ünsal’s academic path reflects her dedication to continuous learning and professional growth in the medical field.

Professional Experience

Dr. Ünsal’s professional journey has been centered on pediatric allergy and immunology. After completing her medical education and residency, she further honed her skills in pediatric immunology during her fellowship at Hacettepe University, one of Turkey’s leading medical institutions. Over the years, Dr. Ünsal has actively contributed to the diagnosis and management of pediatric allergies, asthma, and immunodeficiencies, working in various clinical settings. Her experience spans the diagnosis of IgE-mediated food allergies, asthma exacerbations, and immunodeficiencies, as well as advanced research in these areas. She has gained a reputation for her meticulous approach to clinical research and patient care.

Research Interests

Dr. Ünsal’s research focuses on the intricate relationships between primary immunodeficiencies, genetics, and pediatric allergies. Her specific interests include food allergies, drug allergies, allergic rhinitis, and asthma, with a strong emphasis on understanding the genetic and immunological factors contributing to these conditions in children. She is particularly dedicated to identifying novel allergens and improving diagnostic methods for food allergies, as well as exploring the role of oxidative stress in asthma. Through her research, Dr. Ünsal aims to improve the quality of life for children suffering from these conditions by enhancing early diagnosis, treatment strategies, and prevention methods.

Research Skills

Dr. Ünsal has developed robust research skills, particularly in the areas of biostatistics, immunological testing, and clinical research methodologies. She is proficient in using SPSS for data analysis, enabling her to conduct rigorous statistical evaluations of her research data. Her research skills are further enhanced by her involvement in multiple projects on food allergies, asthma, and immunodeficiencies. Dr. Ünsal’s expertise in interpreting complex immunological data, along with her ability to work with diverse patient populations, has allowed her to contribute to significant studies in her field. Her active participation in both clinical and experimental research ensures that her work remains at the forefront of pediatric allergy and immunology.

Awards and Honors

Dr. Ünsal’s academic and research excellence has been recognized by her peers and academic institutions. As an honor student at Gazi University, she demonstrated early promise in her medical career. Her ongoing contributions to the field of pediatric allergy and immunology have earned her opportunities to present at numerous prestigious conferences, including the European Academy of Allergy and Clinical Immunology (EAACI) Congress and the World Allergy Congress. Additionally, her research has been published in well-regarded journals such as Pediatric Allergy and Immunology and Turkish Journal of Medical Sciences, which highlights her commitment to advancing knowledge in her field.

Conclusion

Dr. Hilal Ünsal is highly deserving of the Best Researcher Award based on her extensive body of work, leadership in research, and active participation in international conferences. Her expertise in pediatric immunology and allergy is well-documented, and her ongoing research in immunodeficiencies and food allergies is crucial for advancing clinical practice in these areas. While further strengthening her clinical impact and broadening her research funding could enhance her profile, her current contributions to the field place her as a prominent figure in her discipline. Dr. Ünsal is well-positioned for continued excellence in research, making her an excellent candidate for this prestigious award

Publication Top Notes

Title: The treatment journey of children with moderate to severe atopic dermatitis in Türkiye: unmet needs
- Authors: İlgün Gürel, D., Ünsal, H., Soyak Aytekin, E., Ersoy Evans, S., Şekerel, B.E.
- Year: 2024
Title: A large single-center cohort of bare lymphocyte syndrome: Immunological and genetic features in Turkey
- Authors: Ünsal, H., Caka, C., Bildik, H.N., Tezcan, İ., Çağdaş, D.
- Year: 2024
- Citations: 2
Title: Cupressus arizonica: an emerging aeroallergen for East Mediterranean children
- Authors: Ünsal, H., Şahiner, Ü.M., Soyer, Ö., Şekerel, B.E.
- Year: 2023
Title: Phenotypes of persistent hen’s egg allergy in children and adolescents
- Authors: Ünsal, H., Dal, S.T., Akarsu, A., Soyer, Ö., Şekerel, B.E.
- Year: 2023
- Citations: 2
Title: Obesity is a risk factor for decrease in lung function after COVID-19 infection in children with asthma
- Authors: Soyak Aytekin, E., Sahiner, U.M., Tuten Dal, S., Sekerel, B.E., Soyer, O.
- Year: 2022
- Citations: 9
Title: IgE mediated legume allergy in east Mediterranean children: A reflection of multiple food allergies
- Authors: Soyak Aytekin, E., Unsal, H., Sahiner, U.M., Soyer, O., Sekerel, B.E.
- Year: 2022
- Citations: 4
Title: Comparison of miRNA expression in patients with seasonal and perennial allergic rhinitis and non-atopic asthma
- Authors: Tunçer, F., Şahiner, Ü.M., Ocak, M., Şekerel, B.E., Birben, E.
- Year: 2022
- Citations: 4
Title: Clinical Validation of the Spirohome Clinic Ultrasonic Spirometer in Child and Adolescent Patients
- Authors: Sekerel, B.E., Unsal, H., Sahiner, U.M., Karakaya, G., Kalyoncu, A.F.
- Year: 2022
- Citations: 5
Title: Food allergy management has been negatively impacted during the COVID-19 pandemic
- Authors: Soyak Aytekin, E., Tüten Dal, S., Ünsal, H., Soyer, Ö., Şekerel, B.E.
- Year: 2021
- Citations: 2
Title: Allergic reactions against COVID-19 vaccines
- Authors: Ünsal, H., Şekerel, B.E., Şahiner, Ü.M.
- Year: 2021
- Citations: 4

Elena Prokopyeva | Immunology and Microbiology | Life Sciences Innovation Award

Posted on 27/08/202427/08/2024 by Shen Awards

Dr. Elena Prokopyeva | Immunology and Microbiology | Life Sciences Innovation Award

Senior Researcher of Novosibirsk state university, Russia.

Elena Prokopyeva is a distinguished researcher and educator based at the Federal Research Center of Fundamental and Translational Medicine in Novosibirsk, Russia. Her academic journey began at Novosibirsk State University and progressed through advanced research positions at institutions like the FBRI State Research Center of Virology and Biotechnology ‘Vector’. Dr. Prokopyeva holds a PhD focused on the phenotypic and genotypic properties of influenza viruses and has made significant contributions to virology, studying various viruses including influenza, coronaviruses, and adenoviruses. Her expertise extends to virological methods, immunohistochemistry, and serological diagnostics. Dr. Prokopyeva has authored numerous high-impact publications, reflecting her extensive research in infectious diseases and cell biology. She is also a reviewer for MDPI and an expert for the Russian Science Foundation. Her achievements, coupled with her teaching roles in embryology and histology, underscore her valuable contributions to the scientific community.

Profile

Education

Elena Prokopyeva completed her undergraduate studies at Novosibirsk State University (NSU) from 2003 to 2009, where she specialized in Natural Science with a focus on Physiology. She pursued her graduate studies at the Institute of Molecular Biology and Biophysics, Siberian Branch of the Russian Academy of Medical Sciences, from 2009 to 2010, earning expertise in Biochemistry. Her research career began in earnest at the FBRI State Research Center of Virology and Biotechnology ‘Vector’, where she was a Researcher Graduate student from 2010 to 2013, focusing on Virology and Cell Biology. Prokopyeva earned her PhD in December 2015 from the same center, with a thesis on the phenotypic and genotypic properties of pandemic influenza A(H1N1)pdm09 virus. She has continued her academic and research activities at the Federal Research Center of Fundamental and Translational Medicine since 2013.

Professional Experience

Elena Prokopyeva has a distinguished career in virology and molecular biology, marked by extensive research and teaching roles. She began her academic journey at Novosibirsk State University, where she pursued undergraduate studies in natural science and later advanced her education with a PhD at the State Research Center of Virology and Biotechnology ‘Vector’. Her professional experience includes significant roles as a researcher at the Federal Research Center of Fundamental and Translational Medicine (FRC FTM) and as a lecturer in “Embryology,” “General Histology,” and “Special Histology” at Novosibirsk State University. Prokopyeva’s expertise spans virological methods, immunofluorescence, and serological diagnostics, with a focus on infectious diseases and cell biology. She has also contributed as a reviewer for MDPI and an expert for the Russian Science Foundation, reflecting her influence in the scientific community.

Research Interest

Elena Prokopyeva’s research primarily focuses on virology, particularly the study of influenza and other respiratory viruses. Her work explores the phenotypic and genotypic properties of pandemic influenza strains and their adaptation in various animal models. Prokopyeva has conducted significant research on the genetic diversity of adenoviruses and the impact of SARS-CoV-2 on respiratory infections in children. Her expertise extends to the characterization of avian and human respiratory viruses, including their interaction with host cells and susceptibility to antiviral treatments. Additionally, Prokopyeva investigates the molecular mechanisms underlying viral pathogenesis and employs advanced techniques such as immunofluorescence, real-time PCR, and electron microscopy to enhance the understanding of infectious diseases. Her contributions aim to improve diagnostic methods and therapeutic strategies for viral infections, reflecting her commitment to advancing the field of virology and infectious disease research.

Research Skills

Elena Prokopyeva possesses a diverse and advanced skill set in research, particularly within virology and infectious diseases. Her expertise includes virological methods such as virus isolation, infection assays, and the determination of virus susceptibility to inhibitors. She is adept in immunofluorescence and immunohistochemistry techniques, essential for studying viral interactions and pathogenesis. Prokopyeva’s proficiency extends to serological diagnostics using hemagglutination and microneutralization assays, as well as molecular techniques like RNA/DNA isolation, real-time PCR, and gel electrophoresis. Her experience with light and electron microscopy further enhances her capability to analyze viral structures and disease mechanisms. Prokopyeva’s role as a reviewer and expert for scientific foundations highlights her strong analytical skills and contributions to advancing the field of virology. Her comprehensive research skills, combined with her active participation in professional organizations, underscore her significant impact and ongoing commitment to her field.

Awards and Recognition

Elena Prokopyeva has earned notable recognition for her research in virology and infectious diseases. Her contributions to the field are highlighted by her role as a reviewer for the MDPI and an expert for the Russian Science Foundation, reflecting her expertise and impact on scientific research. Her work has been published in prestigious journals such as Viruses, Biochemistry (Moscow), and the Journal of Infection in Developing Countries, with high citation rates in Web of Science and Scopus. Prokopyeva’s research on influenza viruses and other pathogens has garnered significant attention, underscoring her expertise in studying viral genetic diversity and pathogenic mechanisms. Additionally, her involvement with the Euro-Asian Society for Infectious Diseases marks her as a key figure in advancing knowledge in her field. These accolades affirm her standing as a distinguished researcher and contribute to her recognition for the Best Researcher Award.

Conclusion

Elena Prokopyeva is a strong candidate for the Best Researcher Award due to her extensive research expertise, impressive publication record, and significant contributions to the field of virology. Her work in understanding and combating viral diseases, coupled with her role in educating future scientists, underscores her value as a researcher. Addressing the areas for improvement could further enhance her standing and impact in the scientific community. Overall, Prokopyeva’s achievements and ongoing contributions make her a worthy candidate for the award.

Publications Top Notes

“Genetic Diversity of the Human Adenovirus C Isolated from Hospitalized Children in Russia (2019–2022)”
- Authors: Kurskaya, O.G., Prokopyeva, E.A., Dubovitskiy, N.A., Shestopalov, A.M., Sharshov, K.A.
- Journal: Viruses
- Year: 2024
- Volume: 16(3)
- Article Number: 386
- Citations: 1
“Constitutive Androstane Receptor Agonist Initiates Metabolic Activity Required for Hepatocyte Proliferation”
- Authors: Mazin, M.E., Perevalova, A.M., Yarushkin, A.A., Gulyaeva, L.F., Pustylnyak, V.O.
- Journal: Biochemistry (Moscow)
- Year: 2023
- Volume: 88(8)
- Pages: 1061–1069
“Changes in the Etiology of Acute Respiratory Infections among Children in Novosibirsk, Russia, between 2019 and 2022: The Impact of the SARS-CoV-2 Virus”
- Authors: Kurskaya, O.G., Prokopyeva, E.A., Sobolev, I.A., Shestopalov, A.M., Sharshov, K.A.
- Journal: Viruses
- Year: 2023
- Volume: 15(4)
- Article Number: 934
- Citations: 8
“Virological and Genetic Characterization of the Unusual Avian Influenza H14Nx Viruses in the Northern Asia”
- Authors: Dubovitskiy, N., Derko, A., Sobolev, I., Shestopalov, A., Sharshov, K.
- Journal: Viruses
- Year: 2023
- Volume: 15(3)
- Article Number: 734
- Citations: 1
“Virological and genetic characteristics of human respiratory syncytial viruses isolated in Russia, 2017-2018”
- Authors: Prokopyeva, E.A., Kurskaya, O.G., Solomatina, M.V., Shestopalov, A.M., Sharshov, K.A.
- Journal: Journal of Infection in Developing Countries
- Year: 2023
- Volume: 17(2)
- Pages: 251–259
- Citations: 2
“Promotion of NR1I3-mediated liver growth is accompanied by STAT3 activation”
- Authors: Mazin, M.E., Yarushkin, A.A., Pustylnyak, Y.A., Prokopyeva, E.A., Pustylnyak, V.O.
- Journal: Molecular Biology Reports
- Year: 2022
- Volume: 49(5)
- Pages: 4089–4093
- Citations: 2
“Low incidence of human coronavirus among hospitalized children in Novosibirsk city, Russia during pre-pandemic period (2013–2020)”
- Authors: Kurskaya, O.G., Prokopyeva, E.A., Anoshina, A.V., Shestopalov, A.M., Sharshov, K.A.
- Journal: Journal of Microbiology, Immunology and Infection
- Year: 2022
- Volume: 55(2)
- Pages: 336–340
- Citations: 3
“Anti-Influenza Activity of Medicinal Material Extracts from Qinghai–Tibet Plateau”
- Authors: Kurskaya, O., Prokopyeva, E., Bi, H., Wei, L., Sharshov, K.
- Journal: Viruses
- Year: 2022
- Volume: 14(2)
- Article Number: 360
- Citations: 7
“Etiology of influenza-like illnesses in the population of Novosibirsk City in the 2018-2019 epidemic season”
- Authors: Kurskaya, O.G., Anoshina, A.V., Leonova, N.V., Shestopalov, A.M., Sharshov, K.A.
- Journal: Russian Journal of Infection and Immunity
- Year: 2021
- Volume: 11(4)
- Pages: 723–736
- Citations: 2
“Activation of the Akt pathway by a constitutive androstane receptor agonist results in β-catenin activation”
- Authors: Yarushkin, A.A., Mazin, M.E., Pustylnyak, Y.A., Prokopyeva, E.A., Pustylnyak, V.O.
- Journal: European Journal of Pharmacology
- Year: 2020
- Volume: 879
- Article Number: 173135
- Citations: 6

Fahimeh Alizadeh | Immunology and Microbiology | Best Researcher Award

Posted on 23/08/202423/08/2024 by Shen Awards

Assoc Prof Dr. Fahimeh Alizadeh | Immunology and Microbiology | Best Researcher Award

Supervisor of Islamic Azad University, Iran.

Dr. Fahimeh Alizadeh is an accomplished researcher and educator in the field of microbial biotechnology, currently serving as an Associate Professor at the Department of Biology, Islamic Azad University, Gachsaran, Iran. With over two decades of experience in academia, she has previously held roles at the Yasooj Branch of Islamic Azad University, including positions as Head of the Department of Biology and Paramedical Sciences. Dr. Alizadeh’s research expertise encompasses microbial interactions, nanoparticle applications, and antifungal and antibacterial agents. Her significant contributions include research on the molecular mechanisms of Candida species, nanoparticle-based therapies, and biofilm formation. She has secured notable research grants and published extensively in high-impact journals. Dr. Alizadeh holds a Ph.D. from the University of Putra Malaysia and a Post-Doctoral fellowship from the same institution. Her extensive publication record and leadership in scientific research underscore her prominent role in her field.

Profile

Education

Fahimeh Alizadeh holds a robust academic background in microbiology and microbial biotechnology. She completed her Bachelor’s and Master’s degrees in Biology-Microbiology at Islamic Azad University, Iran, where she laid the foundation for her specialization. She further advanced her expertise by earning a Ph.D. in Microbial Biotechnology from the University of Putra Malaysia, Malaysia, where she delved into advanced research techniques and microbial interactions. Dr. Alizadeh continued her scholarly journey with a post-doctoral fellowship at the same institution, focusing on cutting-edge microbial biotechnology. Her educational trajectory reflects a strong commitment to understanding microbial systems and advancing biotechnological applications, equipping her with comprehensive knowledge and research capabilities in her field.

Professional Experience

Dr. Fahimeh Alizadeh has an extensive academic and research career, currently serving as an Associate Professor in the Department of Biology at Gachsaran Branch, Islamic Azad University, Iran since 2023. Prior to this role, she was an Assistant Professor at Yasooj Branch, Islamic Azad University from 2000 to 2023, where she also held leadership positions as Head of the Department of Biology and Head of the Department of Paramedical Sciences at different intervals. Her teaching expertise spans across various subjects, including Biology, Medical Biochemistry, Immunology, and Microbiology. Dr. Alizadeh’s research experience is highlighted by her involvement in several significant projects and grants, including studies on microbial interactions, nanoparticles, and antifungal activities. Her contributions to the field are reflected in her numerous journal publications and research grants, underscoring her commitment to advancing scientific knowledge in microbial biotechnology and related disciplines.

Research Interest

Fahimeh Alizadeh’s research interests encompass a wide array of topics in microbial biotechnology and medical microbiology. Her work primarily focuses on exploring molecular mechanisms underlying microbial interactions, particularly involving fungal pathogens such as Candida albicans. She is deeply involved in studying the inhibitory effects of natural compounds and nanoparticles on pathogenic microorganisms and their biofilms. Her research aims to elucidate the molecular targets and mechanisms of antimicrobial agents, including thymol- and carvacrol-loaded nanoparticles, in combating drug-resistant strains and cancer cells. Additionally, Alizadeh investigates the role of transcription factors and signaling molecules in plant-pathogen interactions, emphasizing the defense responses in oil palm against fungal pathogens. Her extensive studies on the molecular and phenotypic characterization of microbial resistance and biofilm formation contribute significantly to the development of novel therapeutic strategies and antimicrobial agents.

Research Skills

Dr. Fahimeh Alizadeh demonstrates exceptional research skills in the field of microbiology and microbial biotechnology. Her expertise encompasses a broad range of techniques and methodologies, including the isolation and characterization of transcription factors, the development of nanoparticles for therapeutic applications, and the study of antifungal and antibacterial properties of natural compounds. Dr. Alizadeh excels in molecular profiling and transcriptomic analysis, employing massive parallel sequencing to investigate gene expression during pathogen interactions. Her research frequently involves complex in vitro and in vivo studies, such as evaluating the inhibitory effects of various compounds on pathogenic microorganisms and cancer cell lines. Her ability to synthesize and analyze data from diverse experimental approaches highlights her proficiency in translating fundamental research into practical applications. This comprehensive skill set underscores her significant contributions to advancing knowledge in microbial biotechnology and therapeutic development.

Awards and Recognition

Dr. Fahimeh Alizadeh has garnered notable recognition for her impactful contributions to microbial biotechnology and her extensive research in the field. She has been acknowledged for her groundbreaking work on the molecular mechanisms of antifungal agents and nanoparticles in combating resistant pathogens. Her research projects, such as the study on thymol- and carvacrol-loaded nanoparticles and Candida species, have significantly advanced the understanding of antifungal resistance mechanisms. Dr. Alizadeh’s publications in prominent journals, including Pharmaceutical Sciences and Applied Biochemistry and Biotechnology, highlight her expertise and commitment to advancing medical and environmental microbiology. Her leadership roles as Head of the Department of Biology at Yasooj Branch and her active involvement in international research projects further demonstrate her excellence in academia. These achievements underscore her significant contributions to science and her esteemed position in the research community.

Conclusion

Fahimeh Alizadeh is a highly qualified candidate for the Research for Best Researcher Award, with extensive experience in academia, significant research contributions, and a strong publication record. Her leadership roles and research projects highlight her expertise and commitment to advancing microbial biotechnology.

Publications Top Notes

Anti-cancer activity of secreted aspartyl proteinase protein from Candida tropicalis on human cervical cancer HeLa cells
- Authors: E.P. Kokhdan, P. Khodavandi, M.H. Ataeyan, A. Khodavandi, A. Zaheri
- Year: 2024
Possible Molecular Targeting of Biofilm-Associated Genes by Nano-Ag in Candida albicans
- Authors: M.B. Esfahani, A. Khodavandi, F. Alizadeh, N. Bahador
- Year: 2024
Possibility of intrauterine transmission from mother to fetus/newborn: Systematic review and meta-analysis of diagnostic methods to detect SARS-CoV-2 infection
- Authors: P. Khodavandi, A. Khodavandi, F. Alizadeh, L. Gholizadeh
- Year: 2024
- Citations: 1
Hyphae-specific genes: Possible molecular targets for magnetic iron oxide nanoparticles alone and combined with visible light in Candida albicans
- Authors: P. Khodavandi, A. Hosseini, A. Khodavandi, A. Azizi, M. Gerami
- Year: 2023
- Citations: 1
Antibacterial and Anti-Biofilm Activities of Microbial Synthesized Silver and Magnetic Iron Oxide Nanoparticles Against Pseudomonas aeruginosa
- Authors: M.B. Esfahani, A. Khodavandi, F. Alizadeh, N. Bahador
- Year: 2023
- Citations: 3
Biofilm-associated genes as potential molecular targets of nano-Fe3O4 in Candida albicans
- Authors: M. Baghiat Esfahani, A. Khodavandi, F. Alizadeh, N. Bahador
- Year: 2023
- Citations: 1
Synergistic interaction of fluconazole/ sodium bicarbonate on the inhibition of Candida glabrata phospholipase gene
- Authors: S.M.K. Hosseini, F. Alizadeh, S. Nouripour-Sisakht, A. Khodavandi
- Year: 2022
Resistance profiling of metallo-betalactamase genes in clinical isolates of Enterobacteriaceae: Emergence of multidrug resistance
- Authors: H. Alizadeh, A. Khodavandi, F. Alizadeh, N. Bahador
- Year: 2021
- Citations: 2
Antifungal activity of menthol alone and in combination on growth inhibition and biofilm formation of Candida albicans
- Authors: N. Norouzi, F. Alizadeh, A. Khodavandi, M. Jahangiri
- Year: 2021
- Citations: 15
Association between dietary intake and risk of ovarian cancer: a systematic review and meta-analysis
- Authors: A. Khodavandi, F. Alizadeh, A.F.A. Razis
- Year: 2021
- Citations: 28

Preethinie Punyakumari Jayasekara | Immunology and Microbiology | Best Researcher Award

Posted on 29/07/2024 by Shen Awards

Mrs. Preethinie Punyakumari Jayasekara | Immunology and Microbiology | Best Researcher Award

PhD student at University of New England, Australia.

Mrs. Preethinie Punyakumari Jayasekara is a distinguished researcher with a strong background in veterinary microbiology and molecular biology. She holds a PhD from the University of Reading, an MPhil from the University of Peradeniya, and a BVSc (Hons) from the University of Sri Lanka. Her professional experience spans roles as a Veterinary Research Officer at the Veterinary Research Institute of Sri Lanka, a Government Veterinary Surgeon, and extensive research periods at notable institutions in Laos and Australia. Her research interests focus on disease diagnosis in livestock, antimicrobial resistance, and microbiological quality testing. Jayasekara has authored numerous publications, including conference proceedings and review papers. Her key skills include designing and executing research methodologies, data analysis, and collaboration with various research entities. Her work has contributed significantly to advancements in animal health and production.

Profile

Scopus Profile

Education🎓

Mrs. Preethinie Punyakumari Jayasekara holds an impressive educational background in veterinary science and microbiology. She earned her Bachelor of Veterinary Science with Honours (BVSc) from the University of Sri Lanka, where she laid the foundation for her expertise in animal health. Further advancing her knowledge, she pursued a Master of Philosophy (MPhil) in Microbiology at the University of Peradeniya, Sri Lanka, completing her degree in April 2019. Her MPhil research focused on microbiological quality testing of dairy products, specifically curd and yoghurt, aligning with SLS standards. Mrs. Jayasekara’s academic journey culminated with a Doctorate (PhD) from the University of Reading, Australia. Her doctoral studies further honed her skills in molecular biology, significantly contributing to her research capabilities and expertise in diagnosing and treating animal diseases. This robust educational background underpins her distinguished career in veterinary research and microbiology.

Professional Experience 🏢

Mrs. Preethinie Punyakumari Jayasekara has a diverse and accomplished professional background in veterinary science and microbiology. She served as a Veterinary Research Officer in the Molecular Biology Division at the Veterinary Research Institute, Sri Lanka, from July 2018 to September 2021. In this role, she was responsible for establishing molecular techniques for disease diagnosis, conducting research on animal health, and improving laboratory facilities. Her responsibilities also included data analysis, knowledge transfer, and collaboration with external institutes. Prior to this, she worked as a Government Veterinary Surgeon with the Department of Animal Production and Health, Sri Lanka, from December 2015 to July 2018. Her duties involved diagnosing and treating animal diseases, performing post-mortem examinations, and conducting mobile clinics and vaccination programs. Additionally, Mrs. Jayasekara has extensive experience in molecular biology through her work at the National Animal Health Laboratory in Laos and the Elizabeth Macarthur Agricultural Institute in Australia.

Research Interests 🔬

Mrs. Preethinie Punyakumari Jayasekara’s research interests focus on veterinary microbiology and molecular biology. Her work primarily revolves around the application of molecular techniques for disease diagnosis and animal health research. She is particularly interested in utilizing molecular methods to diagnose and manage diseases affecting livestock, such as eye infections and respiratory diseases in goats. Her research also explores the microbiological quality of dairy products and antimicrobial resistance in bacteria from dairy cattle and the farm environment. Mrs. Jayasekara’s expertise includes nucleic acid extraction, PCR assays, and phylogenetic analysis, which she applies to improve animal health and production. She has contributed to the understanding of disease constraints in goat production and has been involved in diagnosing and addressing various animal health issues through advanced microbiological techniques.

Award and Honors

Mrs. Preethinie Punyakumari Jayasekara has earned recognition for her significant contributions to veterinary microbiology and molecular biology. Her work, particularly in diagnosing animal diseases and improving animal health, has been highlighted in various scientific conferences. Notably, she presented at the 9th International Conference on Sustainable Animal Agriculture for Developing Countries (SAADC2023), where she discussed topics such as the causation of pinkeye in Lao goats and the impact of diseases on goat production in Lao PDR. Her research has also been acknowledged in several proceedings and scientific journals. Additionally, she has been instrumental in advancing veterinary research through her role at the Veterinary Research Institute in Sri Lanka, where she established techniques for disease diagnosis and contributed to knowledge transfer programs. Her achievements underscore her dedication to improving animal health and advancing veterinary science.

Research Skills

Mrs. Preethinie Punyakumari Jayasekara possesses extensive research skills, primarily in veterinary microbiology and molecular biology. Her expertise includes sample collection, research planning, and methodology development. She is skilled in designing and selecting primers and probes, performing nucleic acid extraction, and conducting PCR assays. Her proficiency extends to data analysis using tools such as MS Excel, RStudio, Geneious Prime, and Mega10. Jayasekara has practical experience with agarose gel electrophoresis, PCR product purification, and phylogenesis. Additionally, she has demonstrated her ability to diagnose animal diseases and develop research techniques at institutions like the National Animal Health Laboratory in Laos and the Elizabeth Macarthur Agricultural Institute in Australia. Her work also involves collaboration with other research divisions and external organizations, contributing to knowledge transfer and advancing research in animal health and production.

Publications Top Notes 📚

Dhanji Rajani | Immunology | Best Researcher Award

Posted on 13/04/2024 by Shen Awards

Dr. Dhanji Rajani | Immunology | Best Researcher Award

Microbiologist at Microcare Laboratory and Tuberculosis research center, India.

Dr. Dhanji Rajani is an accomplished microbiologist with a Ph.D. in Medical Microbiology from Bhavnagar University. His expertise spans laboratory techniques, data analysis, experimental design, and communication. With a robust educational background, including a B.Sc. in Microbiology and an M.Sc. in Medical Microbiology, Dr. Rajani has honed his research skills over years of professional experience. Proficient in microbiological methods and molecular biology techniques, he excels in culturing microorganisms and conducting advanced molecular analyses. Dr. Rajani’s ability to critically evaluate scientific literature enables him to formulate research hypotheses effectively. He communicates research findings through peer-reviewed publications and scientific presentations, contributing significantly to the field. Through his dedication to scientific inquiry, Dr. Rajani continues to advance microbiological knowledge and foster collaboration within the scientific community.

Professional Profiles:

Education

Dr. Dhanji Rajani’s educational journey reflects a dedicated pursuit of knowledge and expertise in the field of microbiology. He commenced his academic endeavor by earning a Bachelor of Science (B.Sc) in Microbiology from Sir P P Institute of Science in the year 2000. Building upon this foundation, he furthered his qualifications with a Post Graduate Diploma in Medical Laboratory Technology (PGDMLT) from K K Jani Paramedical Institute in 2001. His academic pursuits culminated in the attainment of a Master of Science (M.Sc) in Medical Microbiology from Aditya Vikram Birla Post Graduate Institute in 2003. Undeterred by the challenges of advanced study, Dr. Rajani pursued a Doctor of Philosophy (Ph.D) in Medical Microbiology at Bhavnagar University, successfully completing his doctoral degree in 2012. Through his rigorous academic training, Dr. Rajani acquired a comprehensive understanding of microbiological principles, laying a solid foundation for his subsequent professional endeavors.

Professional Experience

Dr. Dhanji Rajani’s professional journey is marked by a steadfast commitment to the field of microbiology, where he has made significant contributions through his expertise and dedication. He commenced his professional career as a Microbiologist at Microcare Lab & TRC in August 2004, where he has continued to serve diligently to date. Subsequently, he assumed the role of Chief Microbiologist at Smt R B Shah Mahavir Hospital from September 2009 to October 2013, further enriching his experience and expertise in the field. Through his tenure in these roles, Dr. Rajani has demonstrated exceptional proficiency in microbiological research, diagnostics, and laboratory management, earning recognition for his exemplary performance and contributions to the field.

Research Interest

Dr. Dhanji Rajani’s research interests revolve around exploring innovative approaches in microbiology, with a particular focus on tuberculosis (TB) diagnosis and treatment. His research endeavors encompass a wide array of areas, including the development of novel diagnostic tools for TB, the synthesis and evaluation of antimicrobial agents against TB, and the investigation of green synthesis methods for antimicrobial compounds. Additionally, Dr. Rajani is deeply involved in exploring the molecular mechanisms underlying antimicrobial resistance in TB and developing strategies to combat this global health challenge. His multifaceted research agenda aims to contribute to the advancement of TB management strategies and the development of effective interventions to curb the spread of this infectious disease. Through his interdisciplinary approach and dedication to scientific inquiry, Dr. Rajani strives to make meaningful contributions to the field of microbiology and public health.

Award and Honors

Dr. Dhanji Rajani has received prestigious awards and honors in recognition of his outstanding contributions to the field of microbiology. Among these accolades are the “Best Performance award for TB diagnosis” bestowed by the Surat Municipal Corporation in both 2015 and 2016. These awards underscore Dr. Rajani’s excellence in tuberculosis diagnosis, a critical area of microbiological research aimed at combating this infectious disease. His dedication to advancing diagnostic methods and improving patient care has earned him widespread recognition within the scientific community and beyond.

Research Skills

Dr. Dhanji Rajani is a highly skilled microbiologist with a broad range of expertise in laboratory techniques, data analysis, literature review, experimental design, critical thinking, and communication. With a solid foundation in microbiology stemming from his educational background, including a Ph.D. in Medical Microbiology from Bhavnagar University, Dr. Rajani has honed his research skills over years of professional experience. Proficient in various laboratory methods such as culturing and isolation of microorganisms, as well as advanced molecular biology techniques like PCR and DNA sequencing, he demonstrates a comprehensive understanding of microbiological research methodologies. Moreover, his adeptness in data analysis using statistical tools enables him to derive meaningful insights from research findings. Dr. Rajani’s ability to critically evaluate scientific literature equips him with the knowledge necessary to formulate research hypotheses and design experiments effectively. Additionally, his strong communication skills facilitate the dissemination of research findings through peer-reviewed publications and presentations at scientific conferences, contributing to the advancement of microbiological knowledge and fostering collaboration within the scientific community. Through his dedication to scientific inquiry and commitment to excellence, Dr. Rajani continues to make significant contributions to the field of microbiology.

Publications

Indole clubbed 2,4-thiazolidinedione linked 1,2,3-triazole as a potent antimalarial and antibacterial agent against drug-resistant strain and molecular modeling studies
- Authors: Upadhyay, D.B.; Mokariya, J.A.; Patel, P.J.; …; Sahoo, S.K.; Patel, H.M.
- Year: 2024
Cs2CO3-promoted one-pot synthesis of novel tetrahydrobenzofuran-4(2H)-ones: In vitro antimicrobial, antimalarial activity and in silico docking study
- Authors: Bhalodiya, S.S.; Parmar, M.P.; Upadhyay, D.B.; …; Rajani, D.; Patel, H.M.
- Year: 2024
Exploration of quinazoline-tethered hydroxamic acid derivatives as HDAC inhibitors for anticancer activity: Design, synthesis, molecular docking, and biological evaluation
- Authors: Mishra, S.; Verma, E.; Patil, S.; Rajani, D.P.; Gajbhiye, A.
- Year: 2024
Benzimidazole and piperidine containing novel 1,2,3-triazole hybrids as anti-infective agents: Design, synthesis, in silico and in vitro antimicrobial efficacy
- Authors: Mendapara, J.V.; Vaghasiya, M.D.; Rajani, D.P.; …; Patel, H.; Kumari, P.
- Year: 2024
Identification of novel 4-thiazolidinones as new TcaR inhibitors: Design, synthesis, molecular docking, MD simulation, ADMET and in vitro antibacterial evaluation
- Authors: Vaghasiya, M.D.; Mendapara, J.V.; Vaghasiya, S.P.; …; Patel, H.; Kumari, P.
- Year: 2023
Catalyst-free synthesis of imidazo[5,1-b]quinazolines and their antimicrobial activity
- Authors: Patel, P.J.; Vala, R.M.; Patel, S.G.; …; Berrada, M.; Patel, H.M.
- Year: 2023
Clinicopathological profile of peritoneal tuberculosis and a new scoring model for predicting mortality: an international ID-IRI study
- Authors: Tanoglu, A.; Erdem, H.; Friedland, J.S.; …; Demiray, E.K.D.; Aypak, A.
- Year: 2023
Design, synthesis, molecular docking and in silico ADMET investigations of novel piperidine-bearing cinnamic acid hybrids as potent antimicrobial agents
- Authors: Zala, A.R.; Rajani, D.P.; Kumari, P.
- Year: 2023
Synthesis of novel indole-oxindole clubbed 1,2,3-triazole hybrids: antimicrobial evaluation and molecular docking study
- Authors: Mokariya, J.A.; Patel, R.C.; Rajani, D.P.; Patel, M.P.
- Year: 2023
Microwave-Assisted synthesis of-CF3functionalized 3,4-dihydropyrimidinone/thione/imine derivatives by using potassium phthalimide (PPI) as a green and reusable organocatalyst and their anti-microbial evaluation
- Authors: Odiya, S.P.; Das, S.P.; Boruah, J.J.; Rajani, D.P.
- Year: 2023